Clinical trial
Pilot Study of Minocycline in Huntington's Disease
NCT00277355 · Merit Cudkowicz, Other · Completed
Key facts
| NCT number | NCT00277355 |
|---|---|
| Title | Pilot Study of Minocycline in Huntington's Disease |
| Official title | A Multi-Center, Double-Blind, Pilot Study of Minocycline in Huntington's Disease |
| Lead sponsor | Merit Cudkowicz, Other |
| Collaborators | FDA Office of Orphan Products Development U.S. Fed |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Huntington Disease |
| Intervention type | Drug |
| Interventions | minocycline, Matching placebo |
| Enrollment | 114 |
| Start date | Apr 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Jan 16, 2006 |
| Last update posted | Apr 19, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: